Middle East Pharmaceutical Industries Company (4016.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Middle East Pharmaceutical Industries Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 22.93x | 39.16x | 32.39x | 35.86x | 32.16x | 29.28x |
| P/B Ratio | 5.34x | 8.49x | 6.96x | 7.61x | 7.98x | 8.45x |
| P/S Ratio | 4.83x | 7.94x | 6.30x | 7.04x | 7.42x | 7.07x |
| Profitability | ||||||
| Gross Margin | 62.3% | 61.8% | 61.2% | 58.7% | 58.9% | 56.9% |
| Operating Margin | 23.5% | 23.1% | 23.1% | 23.2% | 26.6% | 26.9% |
| Net Margin | 21.1% | 20.3% | 19.5% | 19.6% | 23.1% | 24.1% |
| EBITDA Margin | 23.5% | 27.1% | 25.2% | 26.8% | 28.9% | 29.6% |
| Liquidity | ||||||
| Current Ratio | 3.13x | 2.65x | 2.45x | 2.22x | 2.29x | 2.66x |
| Quick Ratio | 2.35x | 1.95x | 1.68x | 1.42x | 1.63x | 1.60x |
| Leverage | ||||||
| Debt/Equity | 0.15x | 0.18x | 0.20x | 0.30x | 0.33x | 0.25x |
YoY = year-over-year change. Source: FMP..